Authors
Latest:
Unleashing Their Potential: The Evolving Landscape of DHTsKey considerations in deploying fit-for-purpose digital health technologies in drug development.
Latest:
Managing Biospecimens in Cell and Gene Therapy TrialsPursuing new tools and capabilities in sample logistics, storage, and data analysis.
Latest:
Patient Recruitment Goes High-TechEmerging tools in data analytics, automation, EMR aggregation, and even social media are enabling faster and easier patient recruitment.
Latest:
COVID-19 Pandemic Exemplifies the Benefits of CROsThe adaptability and innovative capacity of CROs highlighted in EUCROF survey.
Latest:
Leveraging AI/Machine Learning as an End-to-End DifferentiatorA well-designed approach can benefit clinical trials from protocol design to site support.
Latest:
Patient-Tested Practices for In-Home TrialsBringing clinical trials to patients’ homes can address existing site-based challenges.
Latest:
The Importance of Real-World Evidence in Medical Research and Drug DevelopmentThe ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its growing importance and vast potential to improve personalized medicine, overall healthcare outcomes, and eventually democratization of scientific facts by general accessibility.
Latest:
Enabling Evidence-Based Study Endpoint SelectionHarnessing advances in digital health technologies for a more precision-measured approach.
Latest:
Teamwork for Better Healthcare Solutions: Merging Clinical and Marketing EffortsIn the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.
Latest:
Harnessing the Power of Scientific SurveillanceStatistical methods used via this technique in centralized monitoring.
Latest:
Oversight Method Identifies Critical Errors Missed by Traditional Monitoring ApproachesStudy Health Check provides early identification of issues related to protocol deviations and determines objective measures of site-specific versus study-wide performance.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Orchestrating Different Levels of a Successful Clinical Study Start-UpSimilar to a world-class symphony, a curated site start-up model can accentuate its individual components and lead to swift starts for clinical trials.
Latest:
The Transformative Power of Data Analytics in Clinical TrialsLeveraging and benchmarking insights to boost efficiency and optimization.
Latest:
COVID-19: A New Era for Clinical Trial Research in Europe?A look at the issues in Europe affecting ongoing trials including data management, measures being taken by sponsors, and more.
Latest:
Implementing ePROs in Arthritis Clinical ResearchThe value of electronic patient-reported outcomes data in this disease setting.
Latest:
5 Strategies for Bridging the Sponsor-Site Tech DivideResults from survey of 100 site personnel suggest a disconnect is present between these stakeholders.
Latest:
Africa is Biosimulation’s Next FrontierThe answers to meeting biosimulation's growing demand for talent may lie in Africa.
Latest:
Regulatory CMC: Enhancing Biologics DevelopmentPreventing delays and accelerating the progression of these critical therapies.
Latest:
Using Digital Technology to Empower Patients and Restore TrustLooking at the road ahead to properly utilizing digital technology in clinical trials.
Latest:
The Impact of Decentralized and Hybrid Trials on Sponsor and CRO CollaborationsTufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.
Latest:
COPD: Therapies on the CuspClinical trials in this area reflect new science, and corresponding challenges in their execution.
Latest:
Beyond the Black Box: Tailoring AI Regulation in HealthcareAs adoption increases, regulatory bodies are becoming more involved in the oversight of artificial intelligence.
Latest:
A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by GradeUsing existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.
